We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Heart Recovery Approach May Broaden Pediatric Transplant Donor Pool

By HospiMedica International staff writers
Posted on 12 Oct 2026

Pediatric heart transplantation is constrained by the limited availability of suitable donor hearts. More...

Children can wait many months for transplant, particularly neonates and infants. Long waiting times are associated with about 20% mortality among children on the waiting list, which includes more than 2,000 children each year. New findings demonstrate that a heart recovery method adapted for pediatric transplantation may expand access to donor organs.

Vanderbilt Health (Nashville, TN, USA), with pediatric heart transplant surgeons at Monroe Carell Jr. Children's Hospital at Vanderbilt, has adapted rapid recovery with extended ultraoxygenated preservation (REUP) for children. The technique was originally developed by Vanderbilt Health’s adult heart transplant team for hearts donated after circulatory death. It is intended to preserve donor hearts without reanimating them before transplantation.

REUP preserves the heart by flushing it with a cold, oxygen-rich solution after death. Existing approaches for donation after circulatory death require reanimation of the donor heart either inside the donor’s body or on specialized perfusion devices. The article states that those approaches can raise ethical concerns in some settings and may be expensive, complex, or limited by patient size.

In a New England Journal of Medicine article, surgeons with the Golisano Pediatric Heart Institute at Monroe Carell and Vanderbilt Health’s adult heart transplant team described recovery and transplantation of five donor hearts in children. The children ranged in age from 2 days to 14 years. Since that report, five more children have been treated using the same approach.

The recipients waited an average of 20 days for transplantation. No donor hearts were discarded, and all recipients demonstrated strong heart function after surgery. None required mechanical circulatory support after transplantation, experienced primary graft dysfunction, or showed evidence of rejection during the study period.

All donor recoveries in the pediatric study occurred in settings where donor heart reanimation was not permitted because of ethical concerns. The investigators noted that without REUP, these hearts would not have been available for transplantation. The article also states that the pediatric program’s early success builds on previous Vanderbilt Health findings demonstrating REUP effectiveness in adults.

“This innovative approach is truly transformative for the field of pediatric heart transplantation. Having the ability to expand the organ donor pool and utilize hearts that would otherwise be discarded is a true blessing for our patients. We are planning on helping other programs advance and adopt this technique to hopefully allow saving many more lives,” said Ziv Beckerman, M.D., associate chief of pediatric cardiac surgery, surgical director of pediatric heart transplantation in the Golisano Pediatric Heart Institute at Monroe Carell and senior author of the NEJM article.

Related Links
Vanderbilt Health
Monroe Carell Jr. Children's Hospital


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Immobilization System
Cranial 4Pi Immobilization
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Annotation platform for pixel-level labeling of free-text findings in 3D chest CT. (Baharoon M, Luo L, Moritz M, et al. ReXGroundingCT: A 3D chest CT dataset for segmentation of findings from free-text reports. NEJM AI. 2026;3(7). doi:10.1056/AIdbp2501220.)

Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology

Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.